Pretreatment with antiplatelet drugs improves the cardiac function after myocardial infarction without reperfusion in a mouse model

BACKGROUND: Reperfusion therapy is known to improve prognosis and limit myocardial damage after myocardial infarction (MI). The administration of antiplatelet drugs prior to percutaneous coronary intervention also proves beneficial to patients with acute MI (AMI). However, a good number of AMI patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Kandi, Yang, Wenlong, Zhang, Mingliang, Sun, Yaping, Zhang, Tiantian, Liu, Junling, Zhang, Junfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105067/
https://www.ncbi.nlm.nih.gov/pubmed/31106840
http://dx.doi.org/10.5603/CJ.a2019.0051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105067/
https://www.ncbi.nlm.nih.gov/pubmed/31106840
http://dx.doi.org/10.5603/CJ.a2019.0051

Ejemplares similares